Conmed (CNMD) Shares Outstanding (2010 - 2026)

Conmed (CNMD) has 17 years of Shares Outstanding data on file, last reported at $31.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.0% year-over-year to $31.3 million; the trailing twelve-month figure through Mar 2026 stood at $31.3 million (changed 0.0% YoY), and the FY2025 full-year result was $31.3 million, changed 0.0% from the prior year.
• Shares Outstanding for Q1 2026 stood at $31.3 million, roughly flat from $31.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $31.3 million in Q2 2022 and bottomed at $31.3 million in Q1 2022.
• The 5-year median for Shares Outstanding is $31.3 million (2022), against an average of $31.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding advanced 0.0%; it then dropped 0.0% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $31.3 million in 2022, then changed by 0.0% to $31.3 million in 2023, then changed by 0.0% to $31.3 million in 2024, then gained by 0.0% to $31.3 million in 2025, then changed by 0.0% to $31.3 million in 2026.
• The last three Shares Outstanding figures came in at $31.3 million (Q1 2026), $31.3 million (Q4 2025), and $31.3 million (Q3 2025), per Business Quant data.

Peer Comparison